BCYC - Company ID 0001761612
The table below shows BICYCLE THERAPEUTICS plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $887.00K | $11.73M | $2.92M | $9.98M | $2.68M | $9.36M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $48.90M | $58.43M | $71.03M | $59.06M | $48.27M | $40.06M |
BICYCLE THERAPEUTICS plc reported annual revenue of $72.59M for fiscal year 2025. That is up 105.8% from $35.27M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $2.06M (FY 2017) to $72.59M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $17.47M |
| $18.86M |
| $18.49M |
| $21.12M |
| $18.26M |
| $15.95M |
| Operating income | -$65.48M | -$65.55M | -$86.60M | -$70.20M | -$63.85M | -$46.65M |
| Income tax | $172.00K | $205.00K | -$231.00K | -$1.09M | -$3.45M | $115.00K |
| Net income | -$60.83M | -$59.10M | -$78.95M | -$60.75M | -$50.80M | -$39.81M |
| EPS (diluted) | -$0.87 | -$0.85 | -$1.14 | -$0.88 | -$0.74 | -$0.77 |